Tasca Therapeutics
Cambridge, US · Founded 2021 · 3 known investors
Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.
Founders & leadership
Tasca Therapeutics was founded in 2021 by Xu Wu.
XW
Xu WuFounder
Board
DF
David FallaceBoard director
SL
MA
Michael AbermanBoard director
DK
Drew KingBoard director
MC
Milenko CicmilBoard director
PT
Praveen TipirneniBoard director
Investors · 3
Funding
SEC filings, press & company announcements$100.1M disclosed across 2 rounds · 2024
- $52MSeries ADec 2024 · 2 sourcesSource ↗
▶$48.1MraisedDec 2025 · 9 investors · BiotechnologyRule 506(b)
▶$48.1MraisedDec 2025 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Praveen TipirneniDirector
- David FallaceDirector
- Seth LieblichDirector
- Michael AbermanDirector
- Drew KingExecutive Officer
- Milenko CicmilExecutive Officer, Director
- Xu WuDirector
- Offering amount
- $70.2M
- Amount sold
- $48.1M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Tasca Therapeutics do?
- Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.
- Who founded Tasca Therapeutics?
- Tasca Therapeutics was founded by Xu Wu in 2021.
- Who are Tasca Therapeutics's investors?
- Tasca Therapeutics's investors include 8VC, Cure Ventures, SOSV.
- How much funding has Tasca Therapeutics raised?
- Tasca Therapeutics has disclosed $100.1M raised across 2 rounds.
- Where is Tasca Therapeutics headquartered?
- Tasca Therapeutics is headquartered in Cambridge, US.